GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Ending Cash Position

CrystalGenomics Invites Co (XKRX:083790) Ending Cash Position : ₩23,323.5 Mil (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Ending Cash Position?

CrystalGenomics Invites Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩23,323.5 Mil.

CrystalGenomics Invites Co's quarterly Ending Cash Position declined from Sep. 2023 (₩49,820.0 Mil) to Dec. 2023 (₩23,011.3 Mil) but then increased from Dec. 2023 (₩23,011.3 Mil) to Mar. 2024 (₩23,323.5 Mil).

CrystalGenomics Invites Co's annual Ending Cash Position declined from Dec. 2021 (₩30,954.9 Mil) to Dec. 2022 (₩29,963.6 Mil) and declined from Dec. 2022 (₩29,963.6 Mil) to Dec. 2023 (₩23,011.3 Mil).


CrystalGenomics Invites Co Ending Cash Position Historical Data

The historical data trend for CrystalGenomics Invites Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co Ending Cash Position Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51,884.97 47,231.87 30,954.95 29,963.65 23,011.32

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37,611.61 60,900.49 49,820.04 23,011.32 23,323.46

CrystalGenomics Invites Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CrystalGenomics Invites Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=29963.647+-6952.329
=23,011.3

CrystalGenomics Invites Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=23011.318+312.137
=23,323.5


CrystalGenomics Invites Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines